Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling

被引:194
|
作者
Ai, M
Holmen, SL
Van Hul, W
Williams, BO
Warman, ML
机构
[1] Case Sch Med, Dept Genet, Cleveland, OH 44106 USA
[2] Case Sch Med, Ctr Human Genet, Cleveland, OH USA
[3] Univ Hosp Cleveland, Cleveland, OH 44106 USA
[4] Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI USA
[5] Univ Antwerp, Dept Med Genet, Antwerp, Belgium
[6] Univ Antwerp Hosp, Antwerp, Belgium
关键词
D O I
10.1128/MCB.25.12.4946-4955.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The low-density-lipoprotein receptor-related protein 5 (LRP5), a coreceptor in the canonical Wnt signaling pathway, has been implicated in human disorders of low and high bone mass. Loss-of-function mutations cause the autosomal recessive osteoporosis-pseudoglioma syndrome, and heterozygous missense mutations in families segregating autosomal dominant high bone mass (HBM) phenotypes have been identified. We expressed seven different HBM-LRP5 missense mutations to delineate the mechanism by which they alter Wnt signaling. None of the mutations caused activation of the receptor in the absence of ligand. Each mutant receptor was able to reach the cell surface, albeit at differing amounts, and transduce exogenously supplied Wnt1 and Wnt3a signal. All HBM mutant proteins had reduced physical interaction with and reduced inhibition by DKK1. These data suggest that HBM mutant proteins can transit to the cell surface in sufficient quantity to transduce Wnt signal and that the likely mechanism for the HBM mutations' physiologic effects is via reduced affinity to and inhibition by DKK1.
引用
收藏
页码:4946 / 4955
页数:10
相关论文
共 10 条
  • [1] The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations
    Balemans, Wendy
    Piters, Elke
    Cleiren, Erna
    Ai, Minrong
    Van Wesenbeeck, Liesbeth
    Warman, Matthew L.
    Van Hul, Wim
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 (06) : 445 - 453
  • [2] The Binding Between Sclerostin and LRP5 is Altered by DKK1 and by High-Bone Mass LRP5 Mutations
    Wendy Balemans
    Elke Piters
    Erna Cleiren
    Minrong Ai
    Liesbeth Van Wesenbeeck
    Matthew L. Warman
    Wim Van Hul
    Calcified Tissue International, 2008, 82 : 445 - 453
  • [3] Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling
    Balemans, Wendy
    Devogelaer, Jean-Pierre
    Cleiren, Erna
    Piters, Elke
    Caussin, Emanuelle
    Van Hul, Wim
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (05) : 708 - 716
  • [4] LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST
    Semenov, Mikhail V.
    He, Xi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (50) : 38276 - 38284
  • [5] A novel LRP5 mutation in a patient with increased bone mass results in reduced DKK1-inhibition
    Balemans, W
    Devogelaer, J
    Cleiren, E
    Vann Hul, W
    BONE, 2006, 38 (03) : S6 - S7
  • [6] Temporal expression of Lrp5/6, Dkk1 and other Wnt-signaling components in embryonic, growing, and adult mouse bone.
    Richards, WG
    Pretorius, J
    Li, J
    Lacey, DL
    Simonet, WS
    Paszty, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S126 - S126
  • [7] More severe phenotype of early-onset osteoporosis associated with recessive form of LRP5 and combination with DKK1 or WNT3A
    da Silva, Caroline Caetano
    Ricquebourg, Manon
    Orcel, Philippe
    Fabre, Stephanie
    Funck-Brentano, Thomas
    Cohen-Solal, Martine
    Collet, Corinne
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2021, 9 (06):
  • [8] A Cell-Based Dkk1 Binding Assay Reveals Roles for Extracellular Domains of LRP5 in Dkk1 Interaction and Highlights Differences Between Wild-Type and the High Bone Mass Mutant LRP5(G171V)
    Murrills, Richard J.
    Matteo, Jeanne J.
    Bhat, Bheem M.
    Coleburn, Valerie E.
    Allen, Kristina M.
    Chen, Wei
    Damagnez, Veronique
    Bhat, Ramesh A.
    Bex, Frederick J.
    Bodine, Peter V. N.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 108 (05) : 1066 - 1075
  • [9] Missense Mutations in LRP5 Associated with High Bone Mass Protect the Mouse Skeleton from Disuse- and Ovariectomy-Induced Osteopenia
    Niziolek, Paul J.
    Bullock, Whitney
    Warman, Matthew L.
    Robling, Alexander G.
    PLOS ONE, 2015, 10 (11):
  • [10] Differential binding of Dkk1 to LRP5 and to the high bone mass mutation (G171V) in a radioactive whole cell binding assay.
    Murrills, R. J.
    Matteo, J. J.
    Bhat, B. M.
    Coleburn, V. E.
    Bex, F. J.
    Komm, B. S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S259 - S259